Molecular subtyping of small‐cell lung cancer based on mutational signatures with different genomic features and therapeutic strategies

Small‐cell lung cancer (SCLC) is an exceptionally lethal malignancy characterized by extremely high alteration rates and tumor heterogeneity, which limits therapeutic options. In contrast to non‐small‐cell lung cancer that develops rapidly with precision oncology, SCLC still remains outside the real...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Haiyong, Wu, Shuangxiu, Li, Zhenzhen, Zhang, Chenyue, Shang, Xiaoling, Zhao, Chenglong, Li, Zhenxiang, Lin, Jiamao, Guo, Jun, Wang, Zhehai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
ORIGINAL ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9899606/
https://www.ncbi.nlm.nih.gov/pubmed/36178064
http://dx.doi.org/10.1111/cas.15606

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9899606/
https://www.ncbi.nlm.nih.gov/pubmed/36178064
http://dx.doi.org/10.1111/cas.15606

Ejemplares similares